These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28337336)

  • 1. SAR and identification of 2-(quinolin-4-yloxy)acetamides as
    Phummarin N; Boshoff HI; Tsang PS; Dalton J; Wiles S; Barry Rd CE; Copp BR
    Medchemcomm; 2016 Nov; 7(11):2122-2127. PubMed ID: 28337336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arylvinylpiperazine Amides, a New Class of Potent Inhibitors Targeting QcrB of Mycobacterium tuberculosis.
    Foo CS; Lupien A; Kienle M; Vocat A; Benjak A; Sommer R; Lamprecht DA; Steyn AJC; Pethe K; Piton J; Altmann KH; Cole ST
    mBio; 2018 Oct; 9(5):. PubMed ID: 30301850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring Scaffold Hopping for Novel 2-(Quinolin-4-yloxy)acetamides with Enhanced Antimycobacterial Activity.
    Borsoi AF; Silva Ramos A; Sperotto N; Abbadi BL; Souza Macchi Hopf F; da Silva Dadda A; Scheibler Rambo R; Neves Muniz M; Delgado Paz J; Silveira Grams E; Fries da Silva F; Pissinate K; Galina L; Calle González L; Silva Duarte L; Alberton Perelló M; de Matos Czeczot A; Bizarro CV; Basso LA; Machado P
    ACS Med Chem Lett; 2024 Apr; 15(4):493-500. PubMed ID: 38628799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and biological evaluation of (Quinazoline 4-yloxy)acetamide and (4-oxoquinazoline-3(4H)-yl)acetamide derivatives as inhibitors of Mycobacterium tuberculosis bd oxidase.
    Kumar A; Kumari N; Bhattacherjee S; Venugopal U; Parwez S; Siddiqi MI; Krishnan MY; Panda G
    Eur J Med Chem; 2022 Nov; 242():114639. PubMed ID: 35973312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into the SAR and drug combination synergy of 2-(quinolin-4-yloxy)acetamides against Mycobacterium tuberculosis.
    Giacobbo BC; Pissinate K; Rodrigues-Junior V; Villela AD; Grams ES; Abbadi BL; Subtil FT; Sperotto N; Trindade RV; Back DF; Campos MM; Basso LA; Machado P; Santos DS
    Eur J Med Chem; 2017 Jan; 126():491-501. PubMed ID: 27914363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of 4-Amino-Thieno[2,3-
    Harrison GA; Mayer Bridwell AE; Singh M; Jayaraman K; Weiss LA; Kinsella RL; Aneke JS; Flentie K; Schene ME; Gaggioli M; Solomon SD; Wildman SA; Meyers MJ; Stallings CL
    mSphere; 2019 Sep; 4(5):. PubMed ID: 31511370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of 2-(quinolin-4-yloxy)acetamides in Mycobacterium tuberculosis clinical isolates and identification of their molecular target by whole-genome sequencing.
    Subtil FT; Villela AD; Abbadi BL; Rodrigues-Junior VS; Bizarro CV; Timmers LFSM; de Souza ON; Pissinate K; Machado P; López-Gavín A; Tudó G; González-Martín J; Basso LA; Santos DS
    Int J Antimicrob Agents; 2018 Mar; 51(3):378-384. PubMed ID: 28843821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-(Quinolin-4-yloxy)acetamides Are Active against Drug-Susceptible and Drug-Resistant Mycobacterium tuberculosis Strains.
    Pissinate K; Villela AD; Rodrigues-Junior V; Giacobbo BC; Grams ES; Abbadi BL; Trindade RV; Roesler Nery L; Bonan CD; Back DF; Campos MM; Basso LA; Santos DS; Machado P
    ACS Med Chem Lett; 2016 Mar; 7(3):235-9. PubMed ID: 26985307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antitubercular activity of novel 4-arylalkyl substituted thio-, oxy- and sulfoxy-quinoline analogues targeting the cytochrome bc1 complex.
    Murnane R; Zloh M; Tanna S; Allen R; Santana-Gomez F; Parish T; Brucoli F
    Bioorg Chem; 2023 Sep; 138():106659. PubMed ID: 37336104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitubercular Activity of Novel 2-(Quinoline-4-yloxy)acetamides with Improved Drug-Like Properties.
    Borsoi AF; Alice LM; Sperotto N; Ramos AS; Abbadi BL; Macchi Hopf FS; Silva Dadda AD; Rambo RS; Madeira Silva RB; Paz JD; Pissinate K; Muniz MN; Neves CE; Galina L; González LC; Perelló MA; de Matos Czeczot A; Leyser M; de Oliveira SD; de Araújo Lock G; de Araújo BV; Costa TD; Bizarro CV; Basso LA; Machado P
    ACS Med Chem Lett; 2022 Aug; 13(8):1337-1344. PubMed ID: 35978694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the cytochrome bc
    Wani MA; Dhaked DK
    Mol Divers; 2022 Oct; 26(5):2949-2965. PubMed ID: 34762234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyrrolo[3,4-c]pyridine-1,3(2H)-diones: A Novel Antimycobacterial Class Targeting Mycobacterial Respiration.
    van der Westhuyzen R; Winks S; Wilson CR; Boyle GA; Gessner RK; Soares de Melo C; Taylor D; de Kock C; Njoroge M; Brunschwig C; Lawrence N; Rao SP; Sirgel F; van Helden P; Seldon R; Moosa A; Warner DF; Arista L; Manjunatha UH; Smith PW; Street LJ; Chibale K
    J Med Chem; 2015 Dec; 58(23):9371-81. PubMed ID: 26551248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of protein-ligand binding motions through protein conformational morphing and clustering of cytochrome bc1-aa3 super complex.
    Sindhu T; Rajamanikandan S; Jeyakanthan J; Pal D
    J Mol Graph Model; 2023 Jan; 118():108347. PubMed ID: 36208591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arrival of Imidazo[2,1-b]thiazole-5-carboxamides: Potent Anti-tuberculosis Agents That Target QcrB.
    Moraski GC; Seeger N; Miller PA; Oliver AG; Boshoff HI; Cho S; Mulugeta S; Anderson JR; Franzblau SG; Miller MJ
    ACS Infect Dis; 2016 Jun; 2(6):393-8. PubMed ID: 27627627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved Phenoxyalkylbenzimidazoles with Activity against Mycobacterium tuberculosis Appear to Target QcrB.
    Chandrasekera NS; Berube BJ; Shetye G; Chettiar S; O'Malley T; Manning A; Flint L; Awasthi D; Ioerger TR; Sacchettini J; Masquelin T; Hipskind PA; Odingo J; Parish T
    ACS Infect Dis; 2017 Dec; 3(12):898-916. PubMed ID: 29035551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric Oxide-Dependent Electron Transport Chain Inhibition by the Cytochrome
    Zeng S; Zhang J; Sun M; Zhang X; Cook GM; Zhang T
    Antimicrob Agents Chemother; 2021 Aug; 65(9):e0095621. PubMed ID: 34152815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syntheses and Structure-Activity Relationships of
    Hopfner SM; Lee BS; Kalia NP; Miller MJ; Pethe K; Moraski GC
    Appl Sci (Basel); 2021 Oct; 11(19):. PubMed ID: 36698770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure guided generation of thieno[3,2-
    Hopfner SM; Lee BS; Kalia NP; Miller MJ; Pethe K; Moraski GC
    RSC Med Chem; 2021 Jan; 12(1):73-77. PubMed ID: 34046599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of Mycobacterium tuberculosis Cytochrome
    Moosa A; Lamprecht DA; Arora K; Barry CE; Boshoff HIM; Ioerger TR; Steyn AJC; Mizrahi V; Warner DF
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28760899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Function of the cytochrome bc1-aa3 branch of the respiratory network in mycobacteria and network adaptation occurring in response to its disruption.
    Matsoso LG; Kana BD; Crellin PK; Lea-Smith DJ; Pelosi A; Powell D; Dawes SS; Rubin H; Coppel RL; Mizrahi V
    J Bacteriol; 2005 Sep; 187(18):6300-8. PubMed ID: 16159762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.